A large coalition of business groups in Michigan announced opposition to two state House bills that are part of a 15-bill Republican health care reform package they say will increase insurance premiums.
The business groups are focusing opposition to House Bills 4346 and 4354 related to insulin and oral chemotherapy coverage they say will shift costs to small businesses and “mandate coverages and add unnecessary new regulations to insurers, raising health insurance premiums.”
Late Wednesday afternoon, the Michigan House passed health care reform bills, including HB 4346 and 4354. They take immediate effect.
The coalition includes the Michigan Association of Health Plans, Economic Alliance for Michigan, Small Business Association of Michigan, the Michigan Chamber of Commerce, Detroit Regional Chamber, Grand Rapids Area Chamber of Commerce and the National Federation of Independent Business.
The groups have scheduled a virtual news conference Thursday to further discuss the bills’ impact.
Dominick Pallone, MAHP’s executive director, outlined the coalition’s opposition to the two bills.
“The focus (of the GOP health reform package) is definitely on pharmaceutical costs. But some parts of this package are pretty toxic if you are an employer buying insurance,” said Pallone, noting that many of the 15 proposed bills have been previously discussed the past 10 years.
“You’ve got a bill that caps insulin costs and an oral chemotherapy provision (prohibiting health insurers from charging higher) copays for treatments. What this does is just squeeze the balloon and starts shifting prices and costs to employers.”
In a statement, Michigan League for Public Policy CEO Gilda Jacobs expressed support for several health care reform bills, including HB 4346, which places caps on insulin costs.
“Today’s action shows that pricing residents out of life-sustaining and life-saving medicines and procedures is a concern that resonates in every part of the state and on both sides of the aisle, and we appreciate the Legislature’s bipartisan efforts to tackle these issues, rein in some health care costs, and bring about more transparency in health care,” Jacobs said in a statement.
The American Cancer Society Cancer Action Network said it is happy the House approved HB 4354 that limits copayments for oral chemotherapy treatments.
“This legislation would give chronically ill patients more affordable access to the cancer treatment they need,” the network said in a statement. “It would ensure the out-of-pocket cost to the patient for oral chemotherapy and intravenous chemotherapy are similar. Currently, the out-of-pocket costs for some oral chemotherapy medications are higher than IV medications. This is an unnecessary barrier for some Michiganders.”
But Michigan’s small business insurance premiums are already ninth highest in the nation and mandated coverage could reduce the number of small businesses that cover their workforce, said SBAM. Only about one-third of small businesses with fewer than 50 workers in Michigan cover their employees, the association said.
“These bills will increase those already high premiums at a time when small businesses are struggling,” said Scott Lyon, SBAM’s senior vice president, in an email to Crain’s.
Lyon estimated the bills will cost an additional $57 million in insurance premiums paid by state companies.
“These bills will mean more of those companies will face the difficult decision of cutting off insurance for their workers,” Lyon said.
Pallone said the two bills don’t impact health plans directly, but costs will be shifted to employers in the form of higher premiums for fully insured plans.
“It definitely harms the business community,” he said. “The politics is mind-boggling. It’s a populist approach and you have House Republicans shunning the traditional businesses that they historically try to help.”
Pallone said only 24 percent of the people covered under fully insured group policies or individual health insurance in Michigan would be affected.
In a statement Wednesday, Blue Cross Blue Shield of Michigan said it has concerns about some of the bills.
“While Blue Cross is strongly supportive of policy changes that will directly address the high cost of prescription drugs, we are concerned that many aspects of the House package will have significant unintended consequences,” said Mark Cook, Blue Cross’ vice president for government and regulatory affairs, in an email to Crain’s.
“This will result in cost-shifts to employers, increased administrative burdens on patients, higher prescription drug costs and higher health care costs for everyone,” Cook said. “With more than 800 drugs experiencing price increases since January, we look forward to continued policy discussions on how to address high prescription drug costs without jeopardizing access to care.”
In her 2020 State of the State speech, Gov. Gretchen Whitmer said reducing the costs of prescription drugs would be a key future focus. She said at the time, “We know that the increase in prescription drug costs has just been skyrocketing.”
The Democratic governor is supportive of the legislation that helps contain the cost of prescription drugs, Whitmer spokesman Bobby Leddy said Wednesday.
“The governor is pleased that the House is advancing bipartisan legislation to tackle the cost of prescription drugs,” Leddy said in an email to Crain’s. “No one should have to choose between filling their prescriptions, paying rent or putting food on the table.”
The proposed reforms in the House bills are in line with recommendations from a task force Whitmer formed last year within the Michigan Department of Health and Human Services that examined prescription drug costs and how prices are set, Leddy said.
“The task force’s recommendations, delivered in early 2021, take on greater urgency amidst the COVID-19 pandemic and we look forward to working in a bipartisan way with the Legislature to drive down costs and deliver affordable, accessible health care for Michigan families,” Leddy said.
Highlights of some of the other health reform bills include:
- Pharmacists would have more freedom to discuss medication options and pricing with patients.
- Ending the so-called “gag clauses” that prevent pharmacists from disclosing the prices of generic drugs comparable to those prescribed. Similar federal legislation, sponsored by U.S. Sen. Debbie Stabenow, D-Mich., was adopted in 2018.
- Require the pharmaceutical industry and pharmacy benefit managers to submit quarterly “transparency reports” and bans spread pricing that allows PBMs to recoup fees from drug companies intended for local pharmacies. Last December, the U.S. Supreme Court unanimously ruled that states can regulate the power of pharmacy benefit managers.
- Allow patients to shop for lower-priced medications. Now, some patients are penalized for purchasing prescriptions from out-of-network providers. The bill would allow patients to count money used out-of-network toward yearly out of pocket costs for in-network purchases. Other states have similar laws.
- Out-of-state telehealth providers would be allowed to market services and advise Michiganders.
- Doctors would have the amount of gifts they receive capped from outside vendors or pharmaceutical companies. Now, pharmaceutical representatives can give large gifts to doctors in Michigan, which is done to influence physician prescription choices.
Crain’s Senior Editor Chad Livengood contributed.